KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardlytics (CDLX) Cash from Investing Activities (2017 - 2025)

Cardlytics (CDLX) has disclosed Cash from Investing Activities for 9 consecutive years, with -$2.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Investing Activities rose 44.27% year-over-year to -$2.3 million, compared with a TTM value of -$15.3 million through Dec 2025, up 18.37%, and an annual FY2025 reading of -$15.3 million, up 18.37% over the prior year.
  • Cash from Investing Activities was -$2.3 million for Q4 2025 at Cardlytics, up from -$4.5 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at -$1.4 million in Q4 2023 and bottomed at -$348.4 million in Q2 2021.
  • Average Cash from Investing Activities over 5 years is -$28.3 million, with a median of -$4.0 million recorded in 2024.
  • The sharpest move saw Cash from Investing Activities tumbled 17769.13% in 2021, then soared 98.77% in 2022.
  • Year by year, Cash from Investing Activities stood at -$3.4 million in 2021, then increased by 7.64% to -$3.2 million in 2022, then surged by 56.64% to -$1.4 million in 2023, then tumbled by 198.9% to -$4.1 million in 2024, then soared by 44.27% to -$2.3 million in 2025.
  • Business Quant data shows Cash from Investing Activities for CDLX at -$2.3 million in Q4 2025, -$4.5 million in Q3 2025, and -$4.7 million in Q2 2025.